recovery times. Furthermore, the side effects include scarring, infection, postinflammatory hyperpigmentation, and delayed hypopigmentation. [2] [3] [4] [5] As a result, fully ablative nonfractional ablative CO 2 lasers, once considered the "gold standard" for treatment of facial rhytids and photodamaged skin, have fallen out of favor.
In 2004, Manstein et al described fractional photothermolysis, a novel method for cutaneous remodeling. 6 This technique formed microscopic columns of thermal injury surrounded by viable tissue. This method has been applied for a wide variety of lasers, both ablative and nonablative, with alteration in the density, depth, and pattern generation of these microscopic treatment zones. Numerous reports have shown decreased recovery times and a narrow side-effect profile, likely the result of these preserved areas of intact tissue. [7] [8] [9] [10] [11] [12] With this new fractional technology, there has been a resurgence in the application of ablative therapies for facial rejuvenation. Here, we investigate the outcomes of ablative fractional technology in a cosmetic surgery practice.
Methods
A retrospective chart review was performed on 97 consecutive patients who received 101 treatments with a nonsequential fractional ultrapulse CO 2 laser (Ultrapulse Encore, Active FX, Lumenis Ltd., Santa Clara, CA) between March 2007 and May 2008 for the purpose of aesthetic skin resurfacing. The average length of follow-up was four months (range, two weeks to 19 months). Patient demographics, Fitzpatrick skin type, aesthetic units of the face with laser parameters, and the number of passes, types of anesthesia, pre-and posttreatment care, complications, and side effects were recorded. The length of hyperemia was classified as follows: five weeks, five to eight weeks, or more than eight weeks. All data points were analyzed as possible risk factors for complications. All patients were sent a follow-up survey investigating the level of patient satisfaction ( Figure 1 ).
Laser Treatment
Patients were instructed to discontinue retinoids two weeks prior to the procedure. Each patient began a course of valacyclovir two days pretreatment and continued it for eight days posttreatment.
Procedures were performed under local anesthesia or under conscious sedation starting with topical anesthetic cream applied 45 minutes before the procedure. The patient's face was cleansed and sensory nerve blocks were performed, targeting the supraorbital, infraorbital, and mental nerves. Patients receiving treatment of isolated facial aesthetic units (eg, perioral) were anesthetized appropriately. The laser settings were determined and problem areas received a double and/or triple pass, as dictated by the surgeon. When multiple passes were performed, the epidermis was debrided with a tongue blade between each pass. By performing multiple passes with a density greater than three, the epidermis is completely ablated, leaving an intact dermis with microscopic treatment zones. Theoretically, this procedure would provide a more aggressive treatment while taking advantage of the reduced downtime associated with fractional photothermolysis secondary to intact dermal bridging. The range of laser settings and frequency of passes for each aesthetic unit are depicted in Table 1 . In general, the entire face was treated with feathering onto the neck and down to the clavicles with lighter settings. When treating the periocular region, eye protection was provided with metal eye shields. Of note, CO 2 resurfacing was not performed on skin that was being concurrently undermined secondary to an adjunct procedure such as a rhytidectomy. Posttreatment, patients were seen weekly for four weeks and then every other week for an additional six weeks. A kit with detailed posttreatment instructions was provided to each patient. Early posttreatment dressings consisted of an occlusive ointment (eg, Vaseline) for approximately seven days followed by a "recovery complex" cream that was semi-occlusive (paraffin based) for an additional four to seven days. Patients were instructed to wash frequently with a gentle cleanser. Areas of skin that exhibited fibrous exudates were treated with Vaseline, while areas that were reepithelialized were treated with a paraffin-based moisturizer. Most patients were able to resume a regimen of daily moisturizer, sun block, and/or cover-up makeup by posttreatment week four or at the time of stable epithelialization. Retinoids were resumed at that time as well. Some patients did receive a methylprednisolone dose pack if swelling was determined to be severe.
Results
The average patient age was 53 years (range, 17-76). Ninety-five percent of patients were female (97% Caucasian, 3% Asian). Significant medical history is described in Table 2 . A majority of patients had undergone previous surgical and nonsurgical treatments, as depicted in Table 3 . Patients typically presented with pretreatment findings of perioral lines, uneven pigmentation, and crow's feet (Table 4) . Fitzpatrick skin types are listed in Table 5 .
Local anesthesia was administered in 65.3% of procedures. Those patients receiving their laser resurfacing in conjunction with other cosmetic procedures were typically given general anesthesia (n = 17; 16.8%). The entire face was treated 82.2% (n = 83) of the time, followed by the treatment of isolated facial aesthetic units (Table 6) . Typically, those patients who did not receive full-face resurfacing underwent additional facial cosmetic procedures (eg, facelift) at the time of their resurfacing. A majority of patients received feathering onto the neck and chest region.
Posttreatment hyperemia is shown in Table 7 . Ninetythree percent of patients had less than five weeks of erythema posttreatment. One patient had more than eight weeks of erythema secondary to a contact dermatitis. Fifteen patients had less than five weeks of follow-up. All of these patients had minimal-to-no residual hyperemia at their last visit and were categorized as having less than five weeks of hyperemia. Posttreatment complications were minor and included transient hyperpigmentation, milia, and acne (Table 8) . Anecdotally, patients with hyperpigmentation tended to be those who were noncompliant with the posttreatment skin regimen, failing to apply sun block with early sun exposure. Hyperpigmentation generally occurred three to four weeks posttreatment and lasted, on average, 5.7 weeks (range, two to 12). The laser settings for these patients were not significantly different from those of other patients, but the skin types were statistically higher (III-V). All cases resolved with application of hydroquinones. One patient with a history of multiple lower lid blepharoplasties did experience a transient ectropion. She was treated with the following settings: energy of 125 mJ, frequency of 150 Hz, shape of three, size of seven, and density of six. Her ectropion did not result in any exposure keratitis and was edema related. It resolved after four weeks of treatment with eye lubricants and gentle massage.
No patients experienced posttreatment hypopigmentation or herpes outbreaks. Four patients went on to receive additional laser treatments during the study period because of the severity of their underlying rhytids. In general, these patients were pleased with their results and, initially, the need for multiple treatments was discussed. Representative clinical cases are depicted in Figures 2 through 4 .
Sixty-six patients responded to the five-point Likert scale satisfaction survey (Figure 1 ), equating to a response rate of 68%. Table 9 outlines the responses to individual questions. The following posttreatment complaints were recorded: intraoperative pain (n = 4), as well as pigmentary changes, visible patterns, length of recovery time, ocular irritation, and acne outbreak (all n = 2). All of these reported complications were transient in nature.
disCussion
This study describes the experience of one cosmetic surgery practice's application of ablative fractional CO 2 lasers for the purpose of nonsurgical facial rejuvenation. For Fractional CO 2 lasers serve as an excellent adjuvant to surgical procedures in providing safe, efficacious, predictable, and positive clinical outcomes for challenging treatment areas. These lasers focus on the outer skin envelope by addressing texture, color, elasticity, fine-line wrinkles, and deep rhytids, whereas issues such as jowling and neck redundancy are best addressed surgically. On this point, education is a key component of the pretreatment evaluation. We strongly reinforce that laser resurfacing will not replace surgical treatments focused on altering volumetric changes as a result of aging. Posttreatment erythema lasting up to four months has been reported with nonfractional ablative CO 2 lasers. 5 In our study, over 93% of patients had less than five weeks of erythema. Other reports have echoed these findings, with anywhere from two days to three weeks of posttreatment erythema being reported. [8] [9] [11] [12] [13] The variability is related to the depth of treatment as a result of the energy selected. Some authors have employed lower settings with multiple treatments, whereas others treat more aggressively. Initially, we elected to treat with lower settings, resulting in less dermal penetration. However, as our experience has grown, we are now treating more aggressively with slightly longer recovery times, resulting in significant improvement in rhytids. Despite the length of erythema, patients usually return to work two to three weeks posttreatment and are able to apply makeup.
One advantage of fractioned CO 2 lasers is the ability to treat patients under local anesthesia, 8 which is generally well tolerated. However, of those patients who reported experiencing difficulty with the procedure, intraoperative pain was the most common complaint. Hence, we offer both local anesthesia and conscious sedation to all patients and encourage sedatives for those patients who express anxiety with regard to the pain associated with the procedure.
Pigmentation changes following CO 2 resurfacing are a major concern. In our cohort, 10 patients experienced postinflammatory hyperpigmentation (PIH), which was transient and controlled with bleaching agents. Tan et al recently reported no episodes of PIH in seven patients (skin types IV and V) treated with a fractional CO 2 laser.
14 This finding is in direct contrast to the experience of Nanni et al, who reported temporary hyperpigmentation in 37% of his patients who underwent traditional ablative CO 2 resurfacing. 5 Our preference is to pretreat patients with glycolic acids, tretinoin, and hydroquinone four to six weeks prior to their CO 2 treatments. This pretreatment, in conjunction with decreased sun exposure and prompt resumption of a skin care regimen approximately four weeks posttreatment, is a primary contributor to our low rate of PIH.
In addition to hyperpigmentation, delayed postoperative hypopigmentation is a frequent occurrence following conventional CO 2 laser treatment, with rates up to 16.3% in some studies. 3 We had no cases of hypopigmentation in this study. However, it is difficult to draw any long-term conclusions, given our short length of follow-up and the reported occurrence of hypopigmentation up to 10 months posttreatment. 5 Case reports of hypertrophic scarring in the neck following ablative fractional CO 2 treatments, usually the result of deep treatments, have also been reported. 15, 16 This side effect did not occur in our series, which may be related to our sequential moderate treatments spaced over four to six months for safer outcomes.
ConClusions
The fractional CO 2 laser is an excellent, less-invasive tool for skin resurfacing, with shorter recovery times and limited side effects. It serves as a safe and reliable method of restoring the outer skin envelope. When patients undergo laser resurfacing as an adjuvant to surgical procedures, maximum facial rejuvenation can be obtained safely, predictably, and efficaciously, resulting in excellent clinical outcomes.
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